Helius Medical Technologies, Inc. - Class A Common Stock (HSDT)
1.3950
+0.5450 (64.12%)
NASDAQ · Last Trade: Jun 11th, 12:16 PM EDT
Detailed Quote
Previous Close | 0.8500 |
---|---|
Open | 1.460 |
Bid | 1.390 |
Ask | 1.400 |
Day's Range | 1.280 - 1.850 |
52 Week Range | 0.7526 - 24.00 |
Volume | 116,356,941 |
Market Cap | 5.20M |
PE Ratio (TTM) | -0.4415 |
EPS (TTM) | -3.2 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 2,639,905 |
Chart
About Helius Medical Technologies, Inc. - Class A Common Stock (HSDT)
Helius Medical Technologies is focused on developing and commercializing innovative medical devices aimed at improving treatment options for patients with neurological conditions, particularly those suffering from disorders resulting from traumatic brain injuries. The company's flagship product is designed to enhance the brain's natural ability to heal itself by leveraging neurotechnology. Helius is committed to advancing the field of neurology through rigorous scientific research and collaborations, ultimately aiming to improve outcomes and quality of life for affected individuals. Read More
News & Press Releases
In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down.
Via Chartmill · June 11, 2025
Via Benzinga · June 11, 2025
Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.
Via Chartmill · June 11, 2025
Via Benzinga · June 11, 2025
-Aetna authorizes claim for PoNS Device at out-of-network negotiated price of $18,350, becoming the third payer to join Anthem and United in providing PoNS reimbursement-
By Helius Medical Technologies, Inc. · Via GlobeNewswire · June 11, 2025
Volume analysis on 2025-06-10: stocks with an unusual volume in today's session.
Via Chartmill · June 10, 2025
Unusual volume stocks in Monday's session
Via Chartmill · June 9, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · June 9, 2025
The market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via Chartmill · June 9, 2025
Via Benzinga · June 9, 2025
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · June 9, 2025
Unusual volume stocks in Friday's session
Via Chartmill · June 6, 2025

Discover the top movers in Friday's pre-market session and stay informed about market dynamics.
Via Chartmill · June 6, 2025

Via Benzinga · June 6, 2025

Via Benzinga · June 5, 2025

Via Benzinga · June 5, 2025

NEWTOWN, Pa., June 04, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced the pricing of its public offering of an aggregate of 2,768,600 shares of its Class A common stock (or common stock equivalents), and warrants to purchase up to 2,768,600 shares of common stock, at a combined public offering price of $3.27 per share and accompanying warrants.
By Helius Medical Technologies, Inc. · Via GlobeNewswire · June 4, 2025

Company previously granted extension until June 30, 2025 to regain compliance with Nasdaq’s Equity Rule requirement
By Helius Medical Technologies, Inc. · Via GlobeNewswire · June 4, 2025
Via Benzinga · May 22, 2025
Shepherd Center’s Dr. Deborah Backus to Showcase Final Results of PoNSTEP Study, Providing New Insight into Maximizing Impact of Neuromodulation to Improve Gait in People with MS
By Helius Medical Technologies, Inc. · Via GlobeNewswire · May 20, 2025
United Healthcare approves claim for PoNS Device at out-of-network adjusted list price, becoming the second payer to join Anthem in providing PoNS reimbursement
By Helius Medical Technologies, Inc. · Via GlobeNewswire · May 12, 2025